Membranes for guided bone regeneration should have a mechanical structure and a chemical composition suitable for mimicking biological structures. In this work, we pursue the development of periosteum-inspired bilayered membranes obtained by crosslinking alginate with different amounts of nanohydroxyapatite. Alginate-nanohydroxyapatite interaction was studied by rheology and infrared spectroscopy measurements. The membranes were characterized regarding their tensile strength, degradation and surface morphology. Finally, cell cultures were performed on each side of the membranes. The ionic bonding between alginate polysaccharide networks and nanohydroxyapatite was proven, and had a clear effect in the strength and microstructure of the hydrogels. Distinct surface characteristics were achieved on each side of the membranes, resulting in a highly porous fibrous side and a mineral-rich side with higher roughness and lower porosity. Moreover, the effect of amount of nanohydroxyapatite was reflected in a decrease of the membranes' plasticity and an increment of degradation rate. Finally, it was proved that osteoblast-like cells proliferated and differentiated on the mineral-rich side, specially when a higher amount of nanohydroxyapatite was used, whereas fibroblasts-like cells were able to proliferate on the fibrous side. These periosteum-inspired membranes are promising biomaterials for guided tissue regeneration applications.
1 May 2017 in Journal of Colloid and Interface Science
Oral diseases represent a significant public health challenge, particularly periodontal and peri-implant diseases that result in considerable bone loss and diminished quality of life. To address these issues, tissue engineering techniques such as guided bone regeneration (GBR) utilize barrier membranes to promote bone defect healing. This study introduces a novel membrane employing Ganoderma sessile mycelium as a microstructural director for osteogenic biomaterials, achieving a mycelium-alginate-nanohydroxyapatite (My-ALG-HA) composite. This innovative strategy addresses the limitations of conventional biomaterials, including inadequate management of chewing forces, limited blood supply and microbial contamination. This approach uses the unique hierarchical structure and hydrophobic properties of Ganoderma mycelium alongside the biocompatibility and hydrophilicity of the ALG-HA system to improve the structural integrity and biological functionality. The mycelium colonizes the ALG-HA substrate, forming a porous trabecular bone-like network. Water contact angle assays indicated an anisotropic interaction behavior, and tensile testing confirmed the material ductility. Incorporating mycelium-derived molecules contributes to its hydrophobicity and resistance to degradation in simulated physiological conditions. Additionally, the My-ALG-HA biomaterial demonstrates human blood hemocompatibility and osteoblast-like cell (MC3T3-E1) cytocompatibility, highlighting its potential as an advanced solution for bone tissue regeneration in regenerative medicine.
Bone defects resulting from injuries or pathologies necessitate advanced filler materials that have evolved from passive integration to active roles in osseointegration and osteoinduction. This study presents the development of a multifunctional composite scaffold based on synthetic nano-hydroxyapatite (HA), sodium alginate (ALG), and calcium phosphate/carbonate cements (CPC) loaded with ciprofloxacin (CIP). The physicochemical behavior was assessed under simulated physiological conditions, revealing a pH-responsive performance: the scaffold maintains initial stability and high swelling at pH 7.4, while undergoing accelerated degradation at pH 4.2, mimicking the environment of active bone resorption. Optical microscopy with crossed polarizers confirmed the formation of birefringent three-dimensional structures (mesophases) that reinforce the matrix and provide a template for tissue organization. Bioactivity assays in simulated body fluid (SBF) demonstrated the progressive growth of biogenic hydroxyapatite, with extensive surface coverage achieved after 28 days, as validated by FE-SEM, XRD, and FT-IR analysis. Furthermore, the system ensures localized CIP release effective against the primary strains causing osteomyelitis while maintaining a hemolysis rate below 1%, confirming its excellent hemocompatibility. These findings establish this integral platform as a promising and safe antibacterial bone filler for localized tissue repair.